KOAN — Resonate Blends, Inc.

OTC · Information Technology · Software · CIK 897078 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 242,355 167,027 -273,719 -966,899 2,563,576 216,895 8,188,484
Jun 2025 452,314 290,118 -206,940 -486,824 1,016,607 13,433 5,467,525
Mar 2025 430,768 290,043 -330,242 -411,818 1,202,091 18,117 5,418,185
Dec 2024 546,310 363,365 -350,664 -577,441 1,854,461 8,048 5,054,040

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,077,064
Investing CF
$128,654
Financing CF
$962,741
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.00
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-29,768,253
Inventory
Receivables
$17,870
ST Investments
EBIT TTM
$-1,176,964
Pretax Income TTM
$-1,781,578
Interest Exp TTM
$604,614
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,231,933
EBITDA
$-1,591,510
Free Cash Flow
$-1,657,840
Enterprise Value
$4,295,630
Total Cash
$18,117
Total Debt
$4,157,348
Shares Out
305,764,106
Trailing EPS
$-0.01
Book Value
$-0.02
ROE
ROA
-28.2%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,703,326 -985,115 -1,732,286 2,362,007 7,058,016 -1,518,510
Dec 2024 1,896,215 -1,697,626 -2,133,208 1,854,461 5,054,040 -1,029,062
Dec 2023 16,468 -399,223 -1,415,979 992,341 3,127,913 11,166
Dec 2022 49,501 -1,389,395 653,627 399,121 1,545,851 -1,428,467
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
MSFT MICROSOFT CORP $3.09T $416.03
ORCL ORACLE CORP $555.25B $193.06
PLTR Palantir Technologies Inc. $313.64B $136.60
SAP SAP SE $204.50B $175.15
CRWD CrowdStrike Holdings, Inc. $170.93B $671.55

News headlines (Yahoo Finance, 1h cache)

Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
2026-04-08 13:30 · Yahoo
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
2026-02-10 15:08 · Yahoo
Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.
2026-02-10 14:30 · Yahoo
Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.
2026-02-06 14:30 · Yahoo
Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue
2026-01-07 14:30 · Yahoo
Apollo Biowellness, Inc., Corporate Status and Merger Update
2025-10-29 13:30 · Yahoo
Apollo Biowellness, Inc., Merger Update
2025-10-09 18:48 · Yahoo
Apollo Biowellness, Inc., Re-Engages GSS Capital
2025-10-08 13:30 · Yahoo
Apollo Biowellness, Inc., to Merge with Revive Regenerative, Inc.
2025-09-17 13:30 · Yahoo
Apollo Biowellness, Inc., Launches New Product Brand
2025-08-21 13:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.